Ciprodex Ophthalmic Solution
Developed to mitigate bacterial conjunctival infections to support local tissue healing and alleviate ocular swelling.
- Category
- Antibiotics
- Active ingredients
- Ciprofloxacin · Dexamethasone
- Route
- Ocular use
- Form
- Ophthalmic Solution
- Strengths
- 0.3% + 0.1% 5ml
Prescription and consultation requirements for Ciprodex Ophthalmic Solution vary by destination and are determined by the fulfilment partner.
Ciprodex Ophthalmic Solution details
- Alternative names
- ciprofloxacin, dexamethasone
- Therapeutic class
- Fluoroquinolone, Glucocorticoid Combination
- Pharmacological class
- Topical Antibacterial and Anti-Inflammatory
- Contraindications
- viral ocular infections; fungal ocular infections
- Minor side effects
- local stinging; blurred vision
- Moderate side effects
- conjunctival redness; mild burning; dry eyes
- Serious side effects
- corneal ulceration, requires immediate medical attention
- Dosage forms
- Ophthalmic Solution
- Administration route
- Ocular use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Alcon Laboratories
- Onset Time
- 24 hours
- Duration
- 8 hours
- Storage instructions
- Store below 25°C.
- Age restrictions
- Approved for children over two years and adults.
Patient summary
developed to mitigate bacterial conjunctival infections to support local tissue healing and alleviate ocular swelling.
Mechanism of action
Ciprofloxacin halts local bacterial cell replication while dexamethasone inhibits tissue inflammatory mediator release inside eye membranes.
Pregnancy and breastfeeding
TGA Category C: High doses show fetal risk in animals. Use caution. Breastfeeding: Consult a doctor.